{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T18:06:49Z","timestamp":1788804409244,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.msard.2021.103274","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:13:47Z","timestamp":1632183227000},"page":"103274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["ProspeCtive study to evaluate efficacy, safety and tOlerability of dietary supplemeNT of Curcumin (BCM95) in subjects with Active relapsing MultIple Sclerosis treated with subcutaNeous Interferon beta 1a 44 mcg TIW (CONTAIN): A randomized, controlled trial"],"prefix":"10.1016","volume":"56","author":[{"given":"Maria","family":"Petracca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Quarantelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Moccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Satelliti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"D'Ambrosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Carotenuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Ragucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Assogna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Capacchione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Lanzillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo Brescia","family":"Morra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2021.103274_bib0001","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1053\/j.ro.2013.09.002","article-title":"Neuroimaging of multiple sclerosis, acute disseminated encephalomyelitis, and other demyelinating diseases","volume":"49","author":"Bester","year":"2014","journal-title":"Semin. Roentgenol."},{"key":"10.1016\/j.msard.2021.103274_bib0002","first-page":"21","article-title":"Chronic demyelination and axonal degeneration in multiple sclerosis: pathogenesis and therapeutic implications","author":"Simkins","year":"2021","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"5","key":"10.1016\/j.msard.2021.103274_bib0038","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/alzrt146","article-title":"Oral curcumin for Alzheimer\u2019s disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study","volume":"4","author":"Ringman","year":"2012","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.msard.2021.103274_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.01564","article-title":"Immunological aspects of approved MS therapeutics","volume":"10","author":"Rommer","year":"2019","journal-title":"Front. Immunol"},{"key":"10.1016\/j.msard.2021.103274_bib0004","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(98)03334-0","article-title":"Randomised double-blind placebo-controlled study of interferon \u03b2-1a in relapsing\/remitting multiple sclerosis","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2021.103274_bib0005","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1212\/WNL.56.12.1628","article-title":"and the University of British Columbia MS\/MRI Analysis Group PRISMS-4: long-term efficacy of interferon-\u03b2-1a in relapsing MS","volume":"56","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2021.103274_bib0006","first-page":"1","article-title":"Current status of neuroprotective and neuroregenerative strategies in multiple sclerosis: a systematic review","author":"Allanach","year":"2021","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2021.103274_bib0007","doi-asserted-by":"crossref","unstructured":"Kremer, D. Akkermann, R. K\u00fcry, P. Dutta, R. Current advancements in promoting remyelination in multiple sclerosis: 2018, doi:10.1177\/1352458518800827.","DOI":"10.1177\/1352458518800827"},{"key":"10.1016\/j.msard.2021.103274_bib0008","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.schres.2014.04.040","article-title":"Therapeutic strategies in multiple sclerosis: a focus on neuroprotection and repair and relevance to schizophrenia","volume":"161","author":"Inglese","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.msard.2021.103274_bib0009","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10072-017-3149-5","article-title":"Therapeutic potential of curcumin for multiple sclerosis","volume":"39","author":"Qureshi","year":"2018","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.msard.2021.103274_bib0010","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.intimp.2009.01.025","article-title":"Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production","volume":"9","author":"Xie","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.msard.2021.103274_bib0011","doi-asserted-by":"crossref","DOI":"10.4172\/2165-7939.1000322","article-title":"Protective effect of curcumin on neural myelin sheaths by attenuating interactions between the endoplasmic reticulum and mitochondria after compressed spinal cord","volume":"5","author":"jun Yu","year":"2016","journal-title":"J. Spine"},{"key":"10.1016\/j.msard.2021.103274_bib0012","doi-asserted-by":"crossref","first-page":"8116","DOI":"10.4049\/jimmunol.174.12.8116","article-title":"Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-\u03baB as potential targets","volume":"174","author":"Kim","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.msard.2021.103274_bib0013","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jneuroim.2019.01.007","article-title":"Nanocurcumin improves regulatory T-cell frequency and function in patients with multiple sclerosis","volume":"327","author":"Dolati","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2021.103274_bib0033","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/brain\/awaa381","article-title":"Non-invasive quantification of inflammation, axonal and myelin injury in multiple sclerosis","volume":"144","author":"Schiavi","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.msard.2021.103274_bib0014","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.intimp.2014.06.035","article-title":"Study of curcumin immunomodulatory effects on reactive astrocyte cell function","volume":"22","author":"Seyedzadeh","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.msard.2021.103274_bib0015","doi-asserted-by":"crossref","unstructured":"Abbott, N.J. Astrocyte \u2013 endothelial interactions and blood \u2013 brain barrier permeability. J Anat. 200, 629-638. doi:10.1046\/j.1469-7580.2002.00064.x.","DOI":"10.1046\/j.1469-7580.2002.00064.x"},{"key":"10.1016\/j.msard.2021.103274_bib0016","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1111\/j.1745-7254.2007.00651.x","article-title":"Curcumin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-stimulated BV2 microglia","volume":"28","author":"Jin","year":"2007","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.msard.2021.103274_bib0017","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.semcdb.2007.06.003","article-title":"MMPs in the central nervous system: where the good guys go bad","volume":"19","author":"Agrawal","year":"2008","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.msard.2021.103274_bib0018","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s10571-012-9816-4","article-title":"Curcumin inhibits LPS-induced CCL2 expression via JNK Pathway in C6 rat astrocytoma cells","volume":"32","author":"Zhang","year":"2012","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.msard.2021.103274_bib0019","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.expneurol.2013.12.016","article-title":"Curcumin protects axons from degeneration in the setting of local neuroinflammation","volume":"253","author":"Tegenge","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.msard.2021.103274_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nutres.2019.05.001","article-title":"Short-term curcumin supplementation enhances serum brain-derived neurotrophic factor in adult men and women: a systematic review and dose\u2013response meta-analysis of randomized controlled trials","volume":"69","author":"Sarraf","year":"2019","journal-title":"Nutr. Res."},{"key":"10.1016\/j.msard.2021.103274_bib0021","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1152\/jn.90418.2008","article-title":"BDNF modulation of NMDA receptors is activity dependent","volume":"100","author":"Crozier","year":"2008","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.msard.2021.103274_bib0022","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1089\/ten.tea.2018.0215","article-title":"Local delivery of brain-derived neurotrophic factor enables behavioral recovery and tissue repair in stroke-injured rats","volume":"25","author":"Obermeyer","year":"2019","journal-title":"Tissue Eng. - Part A"},{"key":"10.1016\/j.msard.2021.103274_bib0023","first-page":"404","article-title":"Noninvasive brain delivery and efficacy of BDNF to stimulate neuroregeneration and suppression of disease relapse in EAE mice","volume":"17","author":"Kopec","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.msard.2021.103274_bib0024","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2021.103274_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.2009.01221.x","article-title":"Black holes in multiple sclerosis: definition, evolution, and clinical correlations","volume":"122","author":"Sahraian","year":"2010","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.msard.2021.103274_bib0026","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.neuroimage.2006.02.024","article-title":"Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data","volume":"31","author":"Smith","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.msard.2021.103274_bib0027","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1212\/01.WNL.0000034080.43681.DA","article-title":"Randomized, comparative study of interferon \u03b2-1a treatment regimens in MS: the evidence trial","volume":"59","author":"Panitch","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2021.103274_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-017-1922-x","article-title":"Neuroprotective properties of curcumin in toxin-base animal models of Parkinson\u2019s disease: a systematic experiment literatures review","volume":"17","author":"Wang","year":"2017","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.msard.2021.103274_bib0029","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2174\/0929867325666180117112610","article-title":"Supplementation with curcuma longa reverses neurotoxic and behavioral damage in models of Alzheimer\u2019s disease: a systematic review","volume":"17","author":"da Costa","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.msard.2021.103274_bib0030","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4103\/0250-474X.44591","article-title":"A pilot cross-over study to evaluate human oral bioavailability of BCM-95\u00ae CG (BiocurcumaxTM), a novel bioenhanced preparation of curcumin","volume":"70","author":"Antony","year":"2008","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.msard.2021.103274_bib0031","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3177\/jnsv.61.37","article-title":"Colloidal submicron-particle curcumin exhibits high absorption efficiency\u2014A double-blind, 3-way crossover study","volume":"61","author":"Sunagawa","year":"2015","journal-title":"J. Nutr. Sci. Vitaminol. (Tokyo)"},{"key":"10.1016\/j.msard.2021.103274_bib0032","first-page":"2021","article-title":"Neuroprotective effect of turmeric extract in combination with its essential oil and enhanced brain bioavailability in an animal model","author":"Banji","year":"2021","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.msard.2021.103274_bib0034","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/WCO.0000000000000559","article-title":"MRI in multiple sclerosis: clinical and research update","volume":"31","author":"Inglese","year":"2018","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.msard.2021.103274_bib0035","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s40120-018-0103-2","article-title":"Monitoring progressive multiple sclerosis with novel imaging techniques","volume":"7","author":"Petracca","year":"2018","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.msard.2021.103274_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2021.652403","article-title":"Translational block in stroke: a constructive and \u201cOut-of-the-Box\u201d reappraisal","volume":"15","author":"Lourbopoulos","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.msard.2021.103274_bib0037","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jagp.2017.10.010","article-title":"Memory and brain amyloid and Tau effects of a bioavailable form of curcumin in non-demented adults: a double-blind, placebo-controlled 18-month trial","volume":"26","author":"Small","year":"2018","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.msard.2021.103274_bib0039","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/jamaneurol.2018.0611","article-title":"Use of vitamins and dietary supplements by patients with multiple sclerosis a review","volume":"75","author":"Evans","year":"2018","journal-title":"JAMA Neurol"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821005411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821005411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:02:01Z","timestamp":1761901321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034821005411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":39,"alternative-id":["S2211034821005411"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2021.103274","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ProspeCtive study to evaluate efficacy, safety and tOlerability of dietary supplemeNT of Curcumin (BCM95) in subjects with Active relapsing MultIple Sclerosis treated with subcutaNeous Interferon beta 1a 44 mcg TIW (CONTAIN): A randomized, controlled trial","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2021.103274","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103274"}}